Vanguard Group’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$23.2M	Buy	3,093,527 +518,405	+20%	+$5.26M	﹤0.01%	2549
2025 Q3	$22.4M	Sell	2,575,122 -161,549	-6%	-$966K	﹤0.01%	2566
2025 Q2	$10.2M	Sell	2,736,671 -20,819	-0.8%	-$73.2K	﹤0.01%	2892
2025 Q1	$8.91M	Sell	2,757,490 -103,018	-4%	-$485K	﹤0.01%	2907
2024 Q4	$15.9M	Buy	2,860,508 +92,791	+3%	+$728K	﹤0.01%	2694
2024 Q3	$29.9M	Buy	2,767,717 +239,537	+9%	+$3.98M	﹤0.01%	2402
2024 Q2	$53.1M	Buy	2,528,180 +188,237	+8%	+$4.72M	﹤0.01%	2121
2024 Q1	$74.6M	Buy	2,339,943 +473,094	+25%	+$12.1M	﹤0.01%	2006
2023 Q4	$37.8M	Sell	1,866,849 -35,618	-2%	-$469K	﹤0.01%	2304
2023 Q3	$24.2M	Sell	1,902,467 -70,635	-4%	-$1.18M	﹤0.01%	2472
2023 Q2	$35.7M	Buy	1,973,102 +427,218	+28%	+$7.87M	﹤0.01%	2345
2023 Q1	$26.6M	Buy	1,545,884 +273,674	+22%	+$5.32M	﹤0.01%	2461
2022 Q4	$28.3M	Sell	1,272,210 -48,152	-4%	-$744K	﹤0.01%	2468
2022 Q3	$10.6M	Sell	1,320,362 -1,787	-0.1%	-$16.2K	﹤0.01%	2933
2022 Q2	$9.23M	Buy	1,322,149 +31,208	+2%	+$303K	﹤0.01%	3038
2022 Q1	$19.5M	Buy	1,290,941 +7,858	+0.6%	+$123K	﹤0.01%	2790
2021 Q4	$28.2M	Buy	1,283,083 +337,106	+36%	+$8.26M	﹤0.01%	2662
2021 Q3	$25.5M	Buy	945,977 +475,701	+101%	+$13.6M	﹤0.01%	2714
2021 Q2	$11.3M	Buy	470,276 +33,014	+8%	+$1.01M	﹤0.01%	3136
2021 Q1	$19M	Buy	437,262 +427,262	+4,273%	+$18.9M	﹤0.01%	2809
2020 Q4	$414K	Buy	+10,000	New	+$413K	﹤0.01%	3993